HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Weekly Recap

Each week on Saturday morning, the NeurologyLive News Network puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

Severe Preeclampsia Linked With Neuroinflammation, Neurofilament Light Associated With Memory Function, Discrimination Effects on Cognition

August 06, 2022

Neurology News Network for the week ending August 6, 2022. [WATCH TIME: 4 minutes]

FDA Accepts NDA for Tofersen, Serious Falls Increased With Hypnotic Medications, Racial Disparities in Sleep of Pregnant Women

July 30, 2022

Neurology News Network for the week ending July 30, 2022. [WATCH TIME: 4 minutes]

CNM-Au8 Reduces Mortality in ALS, Prenatal Exposure to ASMs Increases Neurodevelopmental Disorders, FDA Grants Tentative Approval to FT218

July 23, 2022

Neurology News Network for the week ending July 23, 2022. [WATCH TIME: 4 minutes]

Apitegromab Continues Positive Efficacy in SMA, Alzheimer Disease Risk Reduced Through Lifestyle Factors, Depressive Trajectories Predict Stroke Risk

July 16, 2022

Neurology News Network for the week ending July 16, 2022. [WATCH TIME: 4 minutes]

FDA Grants Priority Review for Lecanemab, FDA AdComm to Reconvene on AMX0035, Tolebrutinib Trials Suspended Over Safety

July 09, 2022

Neurology News Network for the week ending July 9, 2022. [WATCH TIME: 4 minutes]

Ocrelizumab Reduces Thalamic Volume Loss, Cenobamate Shines in C017 Study, Trial of LRRK2 Inhibitor BIIB122 Commences

July 02, 2022

Neurology News Network for the week ending July 2, 2022. [WATCH TIME: 4 minutes]

AbbVie Submits sNDA for Atogepant in Chronic Migraine, Semorinemab Fails in Phase 2 Prodromal Alzheimer Study, StrivePD Software Gets FDA Greenlight

June 25, 2022

Neurology News Network for the week ending June 25, 2022. [WATCH TIME: 4 minutes]

Erenumab Outperforms Topiramate in PROs, Atogepant Dose-Dependent With Weight Changes, Vutrisiran FDA-Approved for ATTR Amyloidosis

June 18, 2022

Neurology News Network for the week ending June 18, 2022. [WATCH TIME: 3 minutes]

6-Week Natalizumab Dosing Efficacious, MS Cognitive Perceptions, Glatiramer Acetate Depot Shines in Progressive MS

June 11, 2022

Neurology News Network for the week ending June 11, 2022. [WATCH TIME: 3 minutes]

AbbVie Submits NDA for ABBV-951, Periconceptional Folic Acid Supplementation Lowers Preterm Birth Risk, FDA Accepts NDA for Zavegepant

May 28, 2022

Neurology News Network for the week ending May 28, 2022.